Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Merz

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Leukemia|March 31, 2026
Pharmacokinetics of CAR T cells in multiple myeloma - the good, the bad, and the uglyMaximilian Merz, Eric Jurgens, David Fandrei, et al.
Oncology Letters|January 21, 2017
Diagnostic and therapeutic approaches to multiple myeloma patients: 'Real-world' data from representative multicentre treatment surveys in Germany between 2008 and 2011Thomas M Moehler, Maximilian Merz, Lenka Kellermann, et al.
Annals of Hematology|June 30, 2014
Extramedullary relapse after accidental head injury in a patient with multiple myelomaMaximilian Merz, Leonille Schweizer, Modar Kentar, et al.
Annals of Hematology|April 17, 2020
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myelomaMaximilian Merz, Tobias Dechow, Mithun Scheytt, et al.
Oncology Reports|July 5, 2011
Cilengitide inhibits metastatic bone colonization in a nude rat modelMaren Bretschi, Maximilian Merz, Dorde Komljenovic, et al.
Expert Review of Anticancer Therapy|October 10, 2019
The evolving role of maintenance therapy following autologous stem cell transplantation in multiple myelomaAlmuth Maria Anni Merz, Maximilian Merz, Jens Hillengass, et al.
International Journal of Cancer|July 22, 2010
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo studyTobias Bäuerle, Dorde Komljenovic, Maximilian Merz, et al.
Academic Radiology|July 8, 2014
Assessing treatment response of osteolytic lesions by manual volumetry, automatic segmentation, and RECIST in experimental bone metastasesMaren Bretschi, Andrea Fränzle, Maximilian Merz, et al.
Haematologica|February 9, 2018
Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levelsPankaj Yadav, Maximilian Merz, Elias K Mai, et al.
Annals of Hematology|April 15, 2017
Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional surveyMaximilian Merz, Lenka Kellermann, Wolfram Poenisch, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Leukemia|March 31, 2026
Pharmacokinetics of CAR T cells in multiple myeloma - the good, the bad, and the uglyMaximilian Merz, Eric Jurgens, David Fandrei, et al.
Oncology Letters|January 21, 2017
Diagnostic and therapeutic approaches to multiple myeloma patients: 'Real-world' data from representative multicentre treatment surveys in Germany between 2008 and 2011Thomas M Moehler, Maximilian Merz, Lenka Kellermann, et al.
Annals of Hematology|June 30, 2014
Extramedullary relapse after accidental head injury in a patient with multiple myelomaMaximilian Merz, Leonille Schweizer, Modar Kentar, et al.
Annals of Hematology|April 17, 2020
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myelomaMaximilian Merz, Tobias Dechow, Mithun Scheytt, et al.
Oncology Reports|July 5, 2011
Cilengitide inhibits metastatic bone colonization in a nude rat modelMaren Bretschi, Maximilian Merz, Dorde Komljenovic, et al.
Expert Review of Anticancer Therapy|October 10, 2019
The evolving role of maintenance therapy following autologous stem cell transplantation in multiple myelomaAlmuth Maria Anni Merz, Maximilian Merz, Jens Hillengass, et al.
International Journal of Cancer|July 22, 2010
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo studyTobias Bäuerle, Dorde Komljenovic, Maximilian Merz, et al.
Academic Radiology|July 8, 2014
Assessing treatment response of osteolytic lesions by manual volumetry, automatic segmentation, and RECIST in experimental bone metastasesMaren Bretschi, Andrea Fränzle, Maximilian Merz, et al.
Haematologica|February 9, 2018
Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levelsPankaj Yadav, Maximilian Merz, Elias K Mai, et al.
Annals of Hematology|April 15, 2017
Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional surveyMaximilian Merz, Lenka Kellermann, Wolfram Poenisch, et al.
Pageof 13